CRC 1116 "Master switches in cardiac ischemia" (2015-2022)
The fundamental and prospective aim of the CRC 1116 “Master switches in cardiac ischemia” is to identify new targets, i.e. molecules, pathways and mechanisms that are critical for the acute and subacute response to myocardial ischemia, which we define as “master switches”. Importantly, the CRC 1116 considers systemic cross talk of ischemic cardiac injury and systemic inflammatory responses, metabolic comorbidities (obesity, insulin resistance, type 2 diabetes (T2DM)) and anemia.
Prof. Dr. rer. nat. Jens Fischer
0211-81-12500
0211-81-14781
Send Email
Institut für Pharmakologie
Universitätsstr. 1
40225 Düsseldorf
Özlem Gül
0211-81 12507
0211-81 14781
Send Email
Institut für Pharmakologie
Universitätsstr. 1
40225 Düsseldorf
